Chen, W.-L.; Chen, M.-C.; Hsu, S.-F.; Hsiao, S.-H.; Chung, C.-L.
HDAC Inhibitor Abrogates LTA−Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis. Pharmaceuticals 2021, 14, 585.
https://doi.org/10.3390/ph14060585
AMA Style
Chen W-L, Chen M-C, Hsu S-F, Hsiao S-H, Chung C-L.
HDAC Inhibitor Abrogates LTA−Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis. Pharmaceuticals. 2021; 14(6):585.
https://doi.org/10.3390/ph14060585
Chicago/Turabian Style
Chen, Wei-Lin, Mei-Chuan Chen, Shang-Fu Hsu, Shih-Hsin Hsiao, and Chi-Li Chung.
2021. "HDAC Inhibitor Abrogates LTA−Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis" Pharmaceuticals 14, no. 6: 585.
https://doi.org/10.3390/ph14060585
APA Style
Chen, W. -L., Chen, M. -C., Hsu, S. -F., Hsiao, S. -H., & Chung, C. -L.
(2021). HDAC Inhibitor Abrogates LTA−Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis. Pharmaceuticals, 14(6), 585.
https://doi.org/10.3390/ph14060585